AlphaYouDP
Congress trade
Sen. David Perdue (R-GA) bought $1K-$15K of AbbVie Inc. (ABBV) stock
David Perdue, U.S. Senator (R-GA), disclosed a purchase of AbbVie Inc. (ABBV) stock worth $1K-$15K in a STOCK Act filing on May 4, 2018.
The trade happened on Jan 7, 2016, 848 days before it was made public.
ABBV has moved +359.5% since the trade date, from $57.21 to $262.90 (Oct 2, 2026 close).
- Traded
- Jan 7, 2016
- Disclosed
- May 4, 2018
- Filing delay
- 848 days
- Price since
- +359.5%
- Source
- STOCK Act disclosure
Other trades in this disclosure (45)
- BuyAAPL$15K-$50KMay 4, 2018
- BuyKHC$15K-$50KMay 4, 2018
- BuyPG$15K-$50KMay 4, 2018
- BuyAAPL$1K-$15KMay 4, 2018
- BuyAAPL$1K-$15KMay 4, 2018
- BuyAAPL$1K-$15KMay 4, 2018
- BuyAAPL$1K-$15KMay 4, 2018
- BuyBAC$1K-$15KMay 4, 2018
- SellGE$1K-$15KMay 4, 2018
- SellGE$1K-$15KMay 4, 2018
- SellGE$1K-$15KMay 4, 2018
- SellGE$1K-$15KMay 4, 2018
- SellGE$1K-$15KMay 4, 2018
- BuyHYH$1K-$15KMay 4, 2018
- BuyHYH$1K-$15KMay 4, 2018
- BuyHYH$1K-$15KMay 4, 2018
- BuyHYH$1K-$15KMay 4, 2018
- BuyHYH$1K-$15KMay 4, 2018
- BuyHYH$1K-$15KMay 4, 2018
- BuyKN$1K-$15KMay 4, 2018
More ABBV insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.